---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-006190"
form_type: "8-K"
ticker: "MD"
cik: "0000893949"
company_name: "Pediatrix Medical Group, Inc."
filed_at: "2025-01-14T23:59:59+00:00"
generated_at: "2026-05-28T02:33:18.625556+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Mark S. Ordan appointed CEO of Pediatrix Medical Group effective Jan 12, 2025

## Summary
- Mark Ordan, 65, appointed CEO; he was CEO from 2020-2022 and most recently Executive Chair, succeeding Dr. Swift.
- Employment agreement: $1M base salary, $2M one-time cash retention award, annual bonus target 150% of salary.
- Equity transformation award: 640,000 performance share units with stock price hurdles of 125%, 150%, and 175%.
- Annual equity grants of at least $5.5M; severance for cause-less termination: 2x base+bonus, 3x under change in control.
- Dr. Swift's departure is termination without cause; he will receive severance benefits under prior employment agreement.

## SEC filing metadata
- accession: 0001193125-25-006190
- form_type: 8-K
- ticker: MD
- cik: 0000893949
- company_name: Pediatrix Medical Group, Inc.
- filed_at: 2025-01-14T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/893949/000119312525006190/0001193125-25-006190-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/893949/000119312525006190/d855972d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-006190
- JSON: https://secwatch.observer/filing/0001193125-25-006190.json
- Plain text: https://secwatch.observer/filing/0001193125-25-006190.txt

## Key facts
- Executive change
  Mark S. Ordan was appointed as Chief Executive Officer at Pediatrix Medical Group, Inc..
  - Action: appointed
  - Role: Chief Executive Officer
  source text: appointed Mr. Mark S. Ordan to serve as the Company’s Chief Executive Officer and principal executive officer, succeeding Dr. James D. Swift.
  evidence_url: https://www.sec.gov/Archives/edgar/data/893949/000119312525006190/0001193125-25-006190-index.htm
- Executive change
  Dr. James D. Swift departed as other_named_officer at Pediatrix Medical Group, Inc..
  source text: succeeding Dr. James D. Swift.
  evidence_url: https://www.sec.gov/Archives/edgar/data/893949/000119312525006190/0001193125-25-006190-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.